A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

202097 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Leukemia

Volume 35, Issue 3, pp. 701-711

Field-Weighted Citation Impact: 7.58